ARAY (Accuray) FFO


ARAY Accuray Inc ARAY
40 GF Score
Price $0.31
GF Value $1.34
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Accuray FFO?

FFO (Funds from operations) only applies to REITs.

ARAY
40GF Score
Accuray Inc ARAY
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Accuray (ARAY) Overvalued in 2026?

Based on GuruFocus' analysis, Accuray stock appears to be undervalued. The current stock price of $0.31 is trading 77.2% below its estimated GF Value™ of $1.34. GuruFocus considers Accuray to be Possible Value Trap.

Key valuation signals for ARAY:

  • FFO:
  • GF Value™: $1.34 vs. price of $0.31 (77.2% below fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the ARAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Accuray Business Description

Other Exchanges 0H8I:UKXEJ:Germany
Address 1240 Deming Way, Madison, WI, USA, 53717
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
40GF Score

Get the complete analysis for ARAY

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.31
Price
$1.34
GF Value